Soligenix, Inc. announced on July 9 that it has received notice of allowance for European and Canadian patent applications further extending protection around ThermoVax® including coverage of the Company’s ricin toxin vaccine, [Read more]
AntoXa Corporation has obtained a license from Defence Research & Development Canada (DRDC), an Agency of the Canadian Department of National Defence, to develop and produce an anti-ricin monoclonal antibody for sale [Read more]
See what we’re reading this week at Global Biodefense on topics including a National Academies’ report on Dual Use Research of Concern, antibody therapeutics for ricinosis, and questions on inhaled flu vaccine [Read more]
Soligenix, Inc. announced today that it has been granted a Japanese patent (number 6110845) further extending protection around ThermoVax including coverage of the company’s ricin toxin vaccine candidate, RiVax. The technology is [Read more]
Soligenix, Inc. announced today that it has extended its collaboration with IDT Biologika for the manufacture of RiVax, the company’s proprietary heat-stable ricin toxin vaccine. Under the terms of the collaboration, Soligenix [Read more]
Soligenix, Inc. will present preclinical efficacy findings from its RiVax™ ricin toxin vaccine program at the National Organization for Rare Disorders’ (NORD’s) Rare Diseases and Orphan Products Breakthrough Summit on October 17-18, [Read more]
See what we’re reading this week at Global Biodefense on topics including plague vectors, next-generation antibiotics, and mapping zoonotic diseases. POLICY & PRACTICES The disease detective who speaks the truth about epidemics (Foreign Policy) [Read more]
The Food and Drug Administration has announced intentions to issue a sole-source award to Base Pair Biotechnologies to continue development of sensitive assays that can detect deadly ricin toxin. The contract supports the [Read more]
The U.S. Army’s Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) has again chosen Battelle to perform critical medical countermeasures research to protect servicemembers against dangerous infectious disease and chemical threats. [Read more]
See what we’re reading this week at Global Biodefense on topics including influenza surveillance programs, inadequate health emergency preparedness funding, and high containment ambulances. BIODEFENSE POLICY & PRACTICES Resilient health systems can prevent and [Read more]
© 2019 STEMAR MEDIA